What the meltdown in the stock market means for biotech and pharma

On Mon­day, glob­al mar­ket in­dices crashed af­ter a week of soft cor­po­rate earn­ings, a macro­eco­nom­ic warn­ing, and con­cerns that the Fed­er­al Re­serve had wait­ed too …